Sunovion Pharmaceuticals' P2P Acquisition

Sunovion Pharmaceuticals raised a round of funding on November 03, 2009. Investors include Sumitomo Dainippon Pharma.

Sunovion, fka Sepracor, is a pharmaceutical company dedicated to discovering, developing, and commercializing therapeutic products that advance the science of medicine in the central nervous system (C…

Articles about Sunovion Pharmaceuticals' P2P Acquisition: